Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SCANSLEEP SPECIALISTS ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.7% 0.7%   Bankruptcy risk   9.5% 7.2% 2.5% 1.9% 6.9% 14.7% 11.0% 10.9%   Credit score (0-100)   29 36 65 72 35 13 21 21   Credit rating   BB BBB BBB A BBB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,266 1,332 4,229 8,801 623 259 0.0 0.0   EBITDA   26.4 86.3 1,664 2,755 -498 273 0.0 0.0   EBIT   15.3 69.6 1,648 2,750 -498 273 0.0 0.0   Pre-tax profit (PTP)   8.6 67.4 1,645.9 2,761.3 -505.2 306.4 0.0 0.0   Net earnings   5.2 52.2 1,283.6 2,153.7 -430.8 271.4 0.0 0.0   Pre-tax profit without non-rec. items   8.6 67.4 1,646 2,761 -505 306 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Tangible assets total   39.0 22.3 5.6 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   58.2 110 1,394 3,448 1,017 1,288 1,208 1,208   Interest-bearing liabilities   73.1 69.3 179 76.7 33.3 33.3 0.0 0.0   Balance sheet total (assets)   767 550 2,493 5,219 1,432 1,323 1,208 1,208   Net Debt   -203 -159 -389 -3,632 -566 -126 -1,208 -1,208     See the entire balance sheet 1000.0 Volume  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,266 1,332 4,229 8,801 623 259 0.0 0.0   Gross profit growth   0.0% 5.3% 217.4% 108.1% -92.9% -58.5% -100.0% 0.0%   Employees   0 0 0 0 2 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   767 550 2,493 5,219 1,432 1,323 1,208 1,208   Balance sheet change%   0.0% -28.3% 353.5% 109.3% -72.6% -7.6% -8.7% 0.0%   Added value   26.4 86.3 1,664.3 2,755.2 -492.8 273.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   28 -33 -33 -11 -0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   1.2% 5.2% 39.0% 31.2% -80.0% 105.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   2.0% 10.9% 108.5% 71.8% -15.0% 22.6% 0.0% 0.0%   ROI %   11.7% 46.0% 188.4% 108.7% -21.8% 26.2% 0.0% 0.0%   ROE %   9.0% 62.0% 170.6% 89.0% -19.3% 23.5% 0.0% 0.0%   1000.0 Solidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Equity ratio %   7.6% 20.1% 55.9% 66.1% 71.0% 97.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -766.7% -184.5% -23.4% -131.8% 113.6% -46.2% 0.0% 0.0%   Gearing %   125.6% 62.8% 12.8% 2.2% 3.3% 2.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   18.4% 5.8% 4.2% 7.1% 12.9% 13.1% 0.0% 0.0%   1000.0 Liquidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Quick Ratio   1.0 1.1 2.2 3.0 3.4 38.4 0.0 0.0   Current Ratio   1.0 1.2 2.3 3.0 3.4 38.4 0.0 0.0   Cash and cash equivalent   275.7 228.6 567.9 3,709.0 599.4 159.8 0.0 0.0   1000.0 Capital use efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   19.2 81.0 1,381.8 3,488.4 1,014.0 1,288.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 -245 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 -248 0 0 0   EBIT / employee   0 0 0 0 -248 0 0 0   Net earnings / employee   0 0 0 0 -214 0 0 0